StonvexLoading…
StonvexStonvexStonvexCore line items from DFH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $887.84M | $4.32B | $3.11B | $2.14B |
Operating Income | $18.81M | $284.10M | $205.98M | $145.23M |
Net Income | $13.26M | $217.20M | $158.48M | $111.48M |
EPS (Diluted) | $0.11 | $2.14 | $1.56 | $1.10 |
Total Assets | $3.97B | $3.73B | $3.84B | $3.65B |
Total Liabilities | $2.38B | $2.12B | $2.28B | $2.14B |
Cash & Equivalents | $435.38M | $234.77M | $251.04M | $210.32M |
Free Cash Flow OCF − CapEx | $-54.81M | $-126.37M | $-262.40M | $-126.67M |
Shares Outstanding | 92.43M | 101.30M | 101.30M | 101.64M |